Plant Health Care PLC Trading Statement (2016L)
December 21 2018 - 1:00AM
UK Regulatory
TIDMPHC
RNS Number : 2016L
Plant Health Care PLC
21 December 2018
21 December 2018
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Update on 2018 trading
Plant Health Care(R) , a leading provider of novel
patent-protected biological products to global agriculture markets,
provides the following update on trading in 2018.
Key points
- The Company's revenue in 2018 is expected to be broadly in line with last year.
- The launch of a new Harpin <ALPHA><BETA> product
into corn with our major US partner has made a very encouraging
start and delivered sales close to $1.5m. Following discussions
with our partner, we have now agreed to delay the planned launch
into soy, which has comparable market potential, into 2019.
- Expectations for revenue in 2019 remain unchanged.
A significant proportion of the Company's annual sales are
concluded in the final weeks of the year. Overall we now expect
total sales to be broadly in line with those achieved in 2017.
The launch of a novel Harpin <ALPHA><BETA> product
into corn with our major partner in the US has made a very
encouraging start with sales to date close to $1.5m. However,
following discussion with our partner, the launch of a new product
for the soy crop, which has comparable market potential, has now
been delayed, with its associated revenues, until 2019.
In South Africa, which has been a major contributor in prior
years, prolonged drought has resulted in slower draw-down than
expected on in-market inventory. As a result, we have decided to
restrict sales until inventory has been worked off.
Sales in Brazil continue their positive trend in sugarcane, in
line with expectations. Market entry into soy will provide further
upside; although an additional shipment to Brazil may fall into
2019 due to delays in clearing customs.
The balance of these factors means that the Company's revenue in
2018 will be broadly in line with 2017 and materially below market
expectation.
Chris Richards, Executive Chairman and Interim CEO of Plant
Health Care noted: "While the shortfall against expectations is
extremely disappointing, our expectations for sales in 2019 are
unchanged. We are very encouraged by progress in the US and Brazil.
The shortfall in 2018 does not affect the Board's confidence in the
Company becoming cash positive no later than 2020, within our
existing cash reserves."
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
For further information, please contact:
Plant Health Care plc
Chris Richards, Executive Chairman and Interim CEO Tel: +1 919 926 1600
Jeffrey Tweedy, Commercial Head, Americas
Arden Partners plc - Nomad & Broker
John Llewellyn-Lloyd / Dan Gee-Summons Tel: +44 (0) 20 7614
5900
IFC Advisory - Financial PR
Graham Herring / Miles Nolan / Zach Cohen Tel: +44 (0) 20 3934
6633
Company website: www.planthealthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTLFFFIFTLIFIT
(END) Dow Jones Newswires
December 21, 2018 02:00 ET (07:00 GMT)
Plant Health Care (LSE:PHC)
Historical Stock Chart
From Apr 2024 to May 2024
Plant Health Care (LSE:PHC)
Historical Stock Chart
From May 2023 to May 2024